111 related articles for article (PubMed ID: 2790334)
1. Immunomagnetic removal of B-lymphoma cells using a novel mono-sized magnetizable polymer bead, M-280, in conjunction with primary IgM and IgG antibodies.
Kvalheim G; Fjeld JG; Pihl A; Funderud S; Ugelstad J; Fodstad O; Nustad K
Bone Marrow Transplant; 1989 Sep; 4(5):567-74. PubMed ID: 2790334
[TBL] [Abstract][Full Text] [Related]
2. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S
Cancer Res; 1987 Feb; 47(3):846-51. PubMed ID: 3492268
[TBL] [Abstract][Full Text] [Related]
3. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use.
Kvalheim G; Sørensen O; Fodstad O; Funderud S; Kiesel S; Dörken B; Nustad K; Jakobsen E; Ugelstad J; Pihl A
Bone Marrow Transplant; 1988 Jan; 3(1):31-41. PubMed ID: 3048468
[TBL] [Abstract][Full Text] [Related]
4. Relative efficiency of leukemic cell depletion using anti-murine-IgG1(Fc) or anti-murine-IgG coated immunomagnetic microbeads.
Janssen WE; Johnson KS; Lee C; Cassano W
Bone Marrow Transplant; 1990 Jan; 5(1):19-22. PubMed ID: 2297587
[TBL] [Abstract][Full Text] [Related]
5. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
[TBL] [Abstract][Full Text] [Related]
6. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads.
Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C
Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147
[TBL] [Abstract][Full Text] [Related]
7. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
Elias AD; Pap SA; Bernal SD
Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells.
Cragg MS; Zhang L; French RR; Glennie MJ
Br J Cancer; 1999 Feb; 79(5-6):850-7. PubMed ID: 10070880
[TBL] [Abstract][Full Text] [Related]
9. Model experiments for immunomagnetic elimination of leukemic cells from human bone marrow. Presentation of a novel magnetic separation system.
Gruhn B; Häfer R; Müller A; Andrä W; Danan H; Zintl F
Immunobiology; 1991 Nov; 183(5):374-85. PubMed ID: 1786986
[TBL] [Abstract][Full Text] [Related]
10. Immunomagnetic bone marrow purging of common acute lymphoblastic leukemia cells: suitability of BioMag particles.
Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR
Bone Marrow Transplant; 1991 Mar; 7(3):199-203. PubMed ID: 2059757
[TBL] [Abstract][Full Text] [Related]
11. B-1a cell origin of the murine B lymphoma line BCL1 characterized by surface markers and bacterial reactivity of its surface IgM.
Koganei S; Ito M; Yamamoto K; Matsumoto N
Immunol Lett; 2005 May; 98(2):232-44. PubMed ID: 15860223
[TBL] [Abstract][Full Text] [Related]
12. Immunomagnetic removal of L1210V leukemic cells from mouse bone marrow ex vivo.
Wiedłocha A; Paprocka M; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1991; 39(3):235-41. PubMed ID: 1810216
[TBL] [Abstract][Full Text] [Related]
13. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies.
Press OW; Farr AG; Borroz KI; Anderson SK; Martin PJ
Cancer Res; 1989 Sep; 49(17):4906-12. PubMed ID: 2667754
[TBL] [Abstract][Full Text] [Related]
14. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast-specific monoclonal antibodies coupled to magnetic beads provide a rapid and efficient method of purifying avian osteoclasts.
Collin-Osdoby P; Oursler MJ; Webber D; Osdoby P
J Bone Miner Res; 1991 Dec; 6(12):1353-65. PubMed ID: 1792945
[TBL] [Abstract][Full Text] [Related]
16. Purging of small cell lung cancer cells from bone marrow using immunomagnetic beads and a flow-through device.
Ball ED; Powers FJ; Vredenburgh JJ; Heath CA; Converse AO
Bone Marrow Transplant; 1991 Jul; 8(1):35-40. PubMed ID: 1655139
[TBL] [Abstract][Full Text] [Related]
17. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Maruyama S; Kubagawa H; Cooper MD
J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
[TBL] [Abstract][Full Text] [Related]
18. Experimental evaluation of an immunomagnetic bone marrow purging procedure using the Burkitt lymphoma model.
Favrot M; Philip I; Combaret V; Maritaz O; Philip T
Bone Marrow Transplant; 1987 Jun; 2(1):59-66. PubMed ID: 3332158
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
Yamashita T; Koyama J
J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.
Kawamura H; Berzofsky JA
J Immunol; 1986 Jan; 136(1):58-65. PubMed ID: 3079611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
